FRK and diabetes mellitus: β-cell-specific overexpression of FRK renders mice more susceptible to diabetes induction after treatment with streptozotocin (STZ) (37), a glucose homologue that is taken up by the GLUT2 transporter on β-cells and leads to DNA alkylation and apoptosis induction.